<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Cynthia Schuck on Medium]]></title>
        <description><![CDATA[Stories by Cynthia Schuck on Medium]]></description>
        <link>https://medium.com/@cynthiaschuck?source=rss-bd593e71c791------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*jgPJy_PCfHuTiEQ7XsHQOA.jpeg</url>
            <title>Stories by Cynthia Schuck on Medium</title>
            <link>https://medium.com/@cynthiaschuck?source=rss-bd593e71c791------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 11:00:42 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@cynthiaschuck/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Pandemics, global health and the power of consumer choices]]></title>
            <link>https://medium.com/@cynthiaschuck/pandemics-global-health-and-the-power-of-consumer-choices-46bc0d867230?source=rss-bd593e71c791------2</link>
            <guid isPermaLink="false">https://medium.com/p/46bc0d867230</guid>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[coronavirus]]></category>
            <category><![CDATA[antibiotics]]></category>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[epidemic]]></category>
            <dc:creator><![CDATA[Cynthia Schuck]]></dc:creator>
            <pubDate>Thu, 07 May 2020 14:53:19 GMT</pubDate>
            <atom:updated>2020-06-08T14:02:56.961Z</atom:updated>
            <content:encoded><![CDATA[<p>The outbreak of the new coronavirus, SARS-CoV-2, is giving the world a taste of what a respiratory virus pandemic is capable of. If in the age of steam engines the 1918 flu virus spread quickly around the world, it is not surprising that at a time of massive global travel this respiratory virus made its way to all corners of the world in a few weeks. To slow down the infection rate and avoid the collapse of health systems, state of emergency and lock-down measures previously only imagined in science fiction movies were announced in multiple countries. If on the one hand the number of direct victims that this virus will make is still uncertain, on the other there is less doubt about the economic disaster that is already unfolding among the most vulnerable populations.</p><p>Fortunately, the severity of SARS-CoV-2 is not as high as that of the 2002–03 SARS epidemic, where the overall case fatality rate was around 10%, reaching more than 50% in the elderly population. It is difficult to imagine the consequences that such a high lethality would have if combined with the high transmissibility of this new coronavirus. Additionally, the demographic signature of this outbreak is less damaging to the functioning of society than the 1918 or 2009 flu pandemics, which attacked mostly young adults.</p><p>Many in the scientific community talk about the increasing inevitability of pandemics and major disease outbreaks. But is it really inevitable to live under an increasing threat of pandemics and other infectious disease epidemics? Is there anything that can be done not only to mitigate their effects, but to reduce the likelihood of their emergence? If this is our goal, we must rise to the challenge and discuss openly the structural causes underlying these events.</p><figure><img alt="Typical pig growing farm in Spain. Photo: Cynthia Schuck" src="https://cdn-images-1.medium.com/max/1024/1*KIdbzDq-2ygVSvvOQT2-Qw.jpeg" /><figcaption>Typical pig growing facility in the south of Europe. Photo: Cynthia Schuck.</figcaption></figure><h3><strong><em>Infectious Disease Epidemics</em></strong></h3><p>What is the origin of these outbreaks? In the case of the current pandemic, the most likely place of emergence was a wet market in Wuhan, China, where dead and live animals were sold for consumption. Should this hypothesis be confirmed, it would not be not surprising. Over the last century, pandemics and epidemics with pandemic potential predominantly had their origins in the contamination of humans with pathogens from butchered wild animals, or in wild pathogens “cultured” in immunosuppressed animals living in intensive farming systems. This was the case, for example, of the Ebola outbreaks (which still happen), the 2002–2003 SARS epidemics, the swine flu (H1N1pdm) pandemic of 2009 and the multiple avian flu outbreaks. In the latter cases, poultry and swine made the genetic bridge between the wild virus and the virus that finally spread in the human population.</p><p>In response to the coronavirus pandemic, China announced a ban on wildlife trade and consumption (it had also banned it following the 2002–03 SARS outbreak, but the prohibition was similarly short-lived). Although this would be a most welcomed (but late) measure, both in terms of public health and the well-being of animals traded in these markets (often farmed in confinement then kept alive in these markets under conditions of poor hygiene, hunger, thirst, and abuse), it should not create a false sense of security: the risks of infectious disease outbreaks are not restricted to the trade and consumption of wild animals.</p><p>Domesticated species such as chicken, pigs and cattle act as intermediate or amplifier hosts where pathogens can evolve and spill over into humans. Pigs are particularly fit for that purpose, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702078/">acting as mixing vessels</a> for the recombination of genetic material for multiple viral strains. Additionally, the cramming of large populations of animals at high stocking densities in barren and closed environments <a href="https://www.tandfonline.com/doi/full/10.1080/10408410701647594?scroll=top&amp;needAccess=true">promotes the development of high levels of pathogenicity in multiple ways</a>. First, by facilitating the rapid animal-to-animal movement of multiple viral strains and the mixing and recombination of their genetic material. Additionally, viruses are faced with hosts that are incredibly susceptible to infection, where pathogens can multiply rapidly to high levels. Moreover, immunosuppression induced by chronic stress, whereby individuals lose partially the immune response that protects them against infection, is a reality in these systems. Although modern facilities have biosecurity protocols in place, the sheer scale of the outputs of these systems (excrement, live and dead animals, their bodily fluids), the dependence on multiple players in the production chain, the transport of live animals nationally and across borders, and the possibility of contamination of the final products makes those measures insufficient. Examples of outbreaks abound, but perhaps the best known is that of highly pathogenic avian influenza A viruses, or bird flu. The lethality of this virus, which has already infected humans, is incredibly high, with over half of infected people dying. In 2017 and 2018, outbreaks in poultry were reported in multiple Asian and African countries and in 2020, multiple outbreaks have been announced in the Philippines, Germany and the United States. Fortunately, sustained human-to-human transmission is still unlikely, but it might be a matter of time.</p><h3>Losing the battle to infections: antibiotic resistance</h3><p>Before the development of antibiotics, humanity lived in a different world. A small cut, if infected, could be fatal. Surgeries were almost unthinkable. Giving birth was a Russian roulette, as perinatal infections could not be treated. Hospitals were places where little could be done to treat the critically ill. All this changed with the discovery of penicillin in 1928, the first antibiotic. Not only did the treatment of wounds and infections become possible, but also invasive medical procedures, surgeries and chemotherapy. Antibiotics opened the gates to the world as we know today.</p><p>So it is not surprising that the emergence of antimicrobial-resistant bacteria is currently deemed as one of the biggest threats to global health. Pathogens that cause serious medical problems, or complications from these conditions — such as tuberculosis, various sexually transmitted diseases, urinary tract infections, pneumonia, and hospital infections — have now become resistant to a wide range of antibiotics. According to WHO “the world is heading towards a post-antibiotic era in which common infections could kill once again”. In this unfolding scenario, about 700 thousand deaths per year already occur due to antibiotic-resistant infections, with an estimated 10 million deaths per year due to antibiotic-resistant infections in 2050 (more than cancer or diabetes) in a business-as-usual scenario.</p><p>Although part of the problem is the overuse of antibiotics by the human population, what is less talked about is the fact that <a href="https://www.pnas.org/content/112/18/5649.long">most antibiotics (over 70%) sold in the world are not used in humans, but in animals raised in intensive farming systems</a>. In these systems, antimicrobials are widely used not to treat sick animals (which would be justifiable), but prophylactically, to ensure the survival of billions of animals of frail health under the strenuous conditions of factory farms. Not surprisingly, antimicrobial-resistant bacteria have been isolated in several food-producing animals and derived food products (such as chicken and pork meat) sold in traditional supermarkets in nearly every survey that investigated it. <a href="https://www.frontiersin.org/articles/10.3389/fmicb.2019.02091/full">Foods of animal origin can be vehicles for spreading of multi-drug resistance genes</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Zpw4_x_aqmU1qgakW1H1nQ.jpeg" /></figure><h3>Isn’t it time to discuss this inconvenient truth?</h3><p>As far as pathogens with human-to-human transmissibility are concerned, we humans (their hosts) now live in a “big global village”. So the public health logic of “passive-smoking” applies now at a global scale. The borderless dynamics of zoonotic diseases, food contamination and antimicrobial resistance make us all, in some sense, “passive bushmeat eaters”, “passive wet-market visitors”, “passive factory-farm workers” and “passive industrial-meat consumers”.</p><p>We tend to approach each new epidemic and public health crisis independently, rather than recognizing their common drivers. Domesticated animals have been used as food for millennia, but in today’s modern societies we must be honest and admit that the way we raise animals for food is not only unsustainable and unethical, but also a major threat to the human population.</p><p>While large investments are currently being poured into the development of vaccines and treatments to control the damage of the current coronavirus outbreak, these (most needed and welcomed) developments are unlikely to shield us from a future epidemic. We cannot afford not having the same sense of urgency to accelerate the development of modern methods of food production, which include the development of substitutes of animal protein. In fact, this is a revolution in the food sector that has already started, with a diverse range of products on that menu that include meat-like products made from plants or even grown in vats. Ultimately, however, the demand for alternative protein sources must come from the population, and the market will respond appropriately.</p><p>Just as we exercised our citizenship by adopting the necessary measures to curb the advancement of COVID-19 and protect our communities, we must also exercise it with our wallets at the supermarket, and think how best our purchasing and dietary choices can build a safer future for generations to come.</p><p><em>This article is inspired in the e-book </em><strong><em>Pandemics, global health and consumer choices</em></strong><em>, available at </em><a href="http://pandemia2020.org/"><em>http://pandemia2020.org</em></a></p><p>Good books on the topic:</p><p><a href="https://www.amazon.com/Survive-Pandemic-Michael-Greger-FACLM/dp/1250793238"><em>How to survive a pandemic</em></a>. Michael Greger. 2020.</p><p><a href="https://www.amazon.com/Bird-Flu-Virus-Our-Hatching/dp/1590560981/ref=sr_1_1?dchild=1&amp;keywords=Bird+Flu%3A+A+Virus+of+Our+Own+Hatching&amp;qid=1588862897&amp;sr=8-1"><em>Bird Flu: A Virus of Our Own Hatching. Michael Greger. 2006. Lantern Books, USA.</em></a></p><p><a href="https://www.amazon.com/Big-Chicken-Incredible-Antibiotics-Agriculture/dp/1426217668/ref=asap_bc?ie=UTF8"><em>Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eat</em></a><em>s. Maryn McKenna, 2017.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=46bc0d867230" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Expansion of the Alternative Protein Space: Incentives and Approaches]]></title>
            <link>https://medium.com/@cynthiaschuck/expansion-of-the-alternative-protein-space-incentives-and-approaches-d79f415590e?source=rss-bd593e71c791------2</link>
            <guid isPermaLink="false">https://medium.com/p/d79f415590e</guid>
            <category><![CDATA[plant-based]]></category>
            <category><![CDATA[beyond-burger]]></category>
            <category><![CDATA[vegan]]></category>
            <category><![CDATA[animal-agriculture]]></category>
            <category><![CDATA[clean-meat]]></category>
            <dc:creator><![CDATA[Cynthia Schuck]]></dc:creator>
            <pubDate>Sun, 15 Sep 2019 17:33:16 GMT</pubDate>
            <atom:updated>2020-06-08T14:00:35.848Z</atom:updated>
            <content:encoded><![CDATA[<p>The history of humanity has taught us over and again that sole dependence on virtue and compassion is not an effective means to achieve positive social change at a large scale, particularly when it is not aligned with individual interests.</p><p>This is of course not to say that individual interests should always prevail over a common good. Such a system would be (and has been) similarly unstable in the long run for compromising the very societies or groups where individuals live. As put forward by Charles Darwin, ‘<em>moral men might not do any better than immoral men but tribes of moral men certainly “have an immense advantage” over fractious bands of pirates’</em>.</p><p>Instead, the idea is that greater good has been more often achieved by incentive structures capable of aligning individual interests with beneficial outcomes at the societal level. Incentives drive behavior.</p><p>I use this notion to explore the incentive structure behind the expansion of the <em>alternative protein space </em>(plant-based and slaughter-free food markets). Animal agriculture, particularly intensive animal production systems also known as <em>factory farms</em>, are tied to a multitude of problems, from individual and public health issues to environmental losses and animal suffering at unprecedented levels. If we are to promote a sustainable, healthier and more humane food system, we need to ensure that individual incentives are well aligned with the desired outcomes.</p><p>The infographic below shows a broad summary of the main incentives for consuming (red) and abstaining (green) from animal products. On the left, it summarizes (and this is by no means an exhaustive list) some of the strategies that have been used, and the incentives they create, for favoring the latter outcome.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*dLTnRlfbcwQfXJ8J_5-DpA.jpeg" /></figure><p>Existing incentives for consuming animal products are many and diverse: <strong>taste </strong>(a key driver of eating behavior), <strong>tradition </strong>(animal-sourced meals are often part of our culture and social environments), <strong>convenience/ease </strong>(animal products are everywhere, inside and outside our homes), <strong>social status</strong> (until recently, meat eating was a luxury for relatively few), <strong>price </strong>(meat has become incredibly affordable), a belief in still widespread <strong>health myths</strong> (e.g. that animal protein is necessary), the (misinformed) association of animal products with memories of natural and bucolic farm environments (a <strong>rural fantasy</strong> that often brings about in many the idea of a natural and traditional — good — life, but one that hardly fits the current reality of animal agriculture) and the <strong>rejection of the vegetarian (or vegan) identity</strong>, unfortunately still associated with specific stereotypes, political visions, ideologies or even with other social causes that — regardless of their merit — many people do not want to be associated with.</p><p>On the other side, abstinence from animal products is often grounded on the <strong>health benefits of a plant-based diet</strong>, or on <strong>ethical concerns</strong> regarding the environment and the suffering of non-human animals. Such incentives have been enough to take (and keep) many people on this path. Yet for most of the population, information alone is not enough (how many people know of the health risks of smoking or overeating, yet cannot quit these habits?). Even though well-crafted approaches can emphasize the importance of health and ethical concerns as well as reduce the weight of drivers favoring the consumption of animal products, such as the aforementioned health myths, rural fantasies or even the social status of meat eating, the imbalance in the incentive structure shown in the picture’s scale is still large. After all, taste, tradition, price, convenience and social norms are, and have always been, heavy drivers of eating choices.</p><p>The last years have witnessed though an explosion in the number of approaches to make the adoption of animal-free diets easier, such as the rise of the <a href="https://en.wikipedia.org/wiki/Semi-vegetarianism">flexitarian </a>and <a href="https://reducetarian.org/">reducetarian </a>movements, along with campaigns focusing on <a href="https://www.meatfreemondays.com/weekly-meat-free-menu-for-sao-paulo-schools/">gradual change</a> and <a href="https://www.onestepforanimals.org/">easier asks</a>, as well as the expansion of plant-based options in the food service industry — adding more convenience to these dietary choices. Several strategies supporting the growth of the alternative protein market (e.g. <a href="https://ampsinnovation.org/">technological innovation</a>, <a href="https://www.fairr.org/">investor awareness</a>, the creation of <a href="https://plantbasedfoods.org/">interest groups</a>) should also help towards making differences in taste and price between animal and alternative protein choices increasingly less pronounced. In the case of <a href="https://www.new-harvest.org/cell_ag_101">clean (cultivated / slaughter-free) meat</a>, the possibility of not giving up taste, tradition and social status might also be a turning point in driving dietary choices away from animal products for many. When the scale starts tipping to the green side, long-term change might be inevitable.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d79f415590e" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Lost in Translation]]></title>
            <link>https://medium.com/@cynthiaschuck/lost-in-translation-a3f602a256a1?source=rss-bd593e71c791------2</link>
            <guid isPermaLink="false">https://medium.com/p/a3f602a256a1</guid>
            <category><![CDATA[drug-development]]></category>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[state-of-the-union]]></category>
            <category><![CDATA[animal-testing]]></category>
            <category><![CDATA[research-funding]]></category>
            <dc:creator><![CDATA[Cynthia Schuck]]></dc:creator>
            <pubDate>Wed, 20 Feb 2019 15:31:58 GMT</pubDate>
            <atom:updated>2019-02-21T10:00:28.892Z</atom:updated>
            <content:encoded><![CDATA[<h4>How reliance on animal disease models is halting progress in the biomedical sciences</h4><p><em>Written with </em><a href="https://medium.com/@marciatriunfol"><em>Marcia Triunfol</em></a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vK-AQ-tKbt8DpivtJ6qvqw.jpeg" /></figure><p>In his <a href="http://www.webcitation.org/76KWd3D5I">State of the Union address</a> this year, President Trump pledged $500 million over the next 10 years to fund research into cures for childhood cancers. This is in addition to the 21st Century Cures Act approved in December 2016, authorizing $1.8 billion in funding for the <a href="https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative">Cancer Moonshot</a> initiative — a boost in pediatric cancer research funding very much welcomed by the scientific community.</p><p>Unfortunately, research funding — however extensive— is only a piece of the puzzle in the development of new drugs and treatments, for cancer or other ailments. Despite exponential increases in research investment and publication numbers over the last decades, the number of new drugs making their way to patients has remained relatively constant. For example, the bio-pharmaceutical industry has seen inflation-adjusted research costs per novel drug increase nearly<a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147215"> 100 fold in 60 years</a>. In the same period, the number of scientific publications on new drugs increased over 500 percent, and the number of authors 800 percent, per year, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369032/">every year</a>. Yet drugs are more likely to fail today <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147215">than in the 1970s</a> — investment and innovation are very much out of line.</p><p><a href="https://www.pnas.org/content/112/36/11335">Many are the factors</a> slowing therapeutic innovation, including prior resolution of simpler research problems, increasing regulation, a high prevalence of non-reproducible results, obscure methods, poorly designed research and publication biases. Many of these issues would greatly benefit from initiatives that promote transparency at the various stages of the therapeutic development pipeline. It has been widely acknowledged that poor reporting prevents the accurate assessment of drug and intervention efficacy. Preclinical research — i.e. those studies involving <em>in vitro</em> (test tube or cell culture) and <em>in vivo </em>(animal) experiments, conducted before testing a drug in humans to establish efficacy and the drug’s potential to cause serious harm — <a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002273">has been shown</a> to be particularly prone to biases and selective reporting of outcomes, leading to bad decision-making, wasted resources, unnecessary replication of efforts and missed opportunities for the development of effective drugs.</p><p><a href="https://www.nature.com/articles/nbt.2261">One proposal</a> to address this issue is the extension of <a href="http://www.alltrials.net/">good disclosure practice</a> to the preclinical phase by conditioning publication to the registration of the preclinical trial prior to the commencement of the study. Indeed, the exact same reasons that compelled prospective registration and deposition of clinical trial results in public databases apply to preclinical studies.</p><p>Still, no matter how transparent, well-designed, -analyzed and -reported the research, results generated from inappropriate models will not be successfully translated into valid disease contexts. Currently, most preclinical studies are based on the use of animal models, despite increasing evidence that they are an expensive and ineffective option to explore pathophysiological mechanisms, evaluate therapeutics, and decide on whether drug candidates should be carried forward into the clinical phase (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790571/">1</a>, <a href="https://journals.sagepub.com/doi/abs/10.1111/j.1747-4949.2012.00770.x?rfr_dat=cr_pub%3Dpubmed&amp;url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;journalCode=wsoa">2</a>, <a href="https://www.pnas.org/content/110/9/3507">3</a>). Failure rates in the clinical phase <a href="https://www.nature.com/articles/nrd3630">are around 95%</a>, mainly due to the limited power of animal studies to predict new drug efficacy, safety and toxicity in humans. These predictive odds vary depending on the understanding and complexity of disease biology: while for therapeutics targeting infectious diseases success rates are higher, for diseases involving complex mechanisms, such as cancer, they can be as low as 2%.</p><blockquote>Failure rates in the clinical phase are around 95%, mainly due to the limited power of animal models to predict the efficacy, safety and toxicity of new molecular entities in humans. This low predictability drains the entire system by funneling limited resources into outputs that often fail.</blockquote><p>Such low predictability drains the entire system by funneling limited resources into outputs that often fail. In addition, false negatives at the preclinical stage eliminate a large part of potentially new drugs that may have succeeded otherwise. Let us not forget <strong>Aspirin</strong>, a blockbuster drug that would not make the preclinical trial phase if tested today given its unacceptably high toxicity in animal tests. Animal-based preclinical phases are pivotal in explaining the small number of drugs identified in the last decades. Implementation of methods that are more faithful to the human biology is crucial for the much needed progress to ameliorate human disease and suffering.</p><p>Note: this text is based on a comment to an <a href="https://www.pnas.org/content/112/36/11335">article</a> published in the Proceedings of the National Academy of Sciences. The comment was originally published at PubMed Commons in 2015, yet since 2018 PubMed Commons has been <a href="https://www.nature.com/articles/d41586-018-01591-4">discontinued</a>. We are therefore re-publishing an adapted version, as we feel the discussion is still very much needed.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a3f602a256a1" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Meatless Mondays as a national security asset]]></title>
            <link>https://medium.com/@cynthiaschuck/meatless-mondays-as-a-national-security-asset-9f9df1762c30?source=rss-bd593e71c791------2</link>
            <guid isPermaLink="false">https://medium.com/p/9f9df1762c30</guid>
            <category><![CDATA[national-security]]></category>
            <category><![CDATA[meatless-monday]]></category>
            <category><![CDATA[plant-based]]></category>
            <category><![CDATA[preparedness]]></category>
            <category><![CDATA[food-security]]></category>
            <dc:creator><![CDATA[Cynthia Schuck]]></dc:creator>
            <pubDate>Mon, 04 Feb 2019 10:00:51 GMT</pubDate>
            <atom:updated>2019-02-04T11:49:23.215Z</atom:updated>
            <content:encoded><![CDATA[<h4>(don’t tell the enemy!)</h4><p><em>Written together with </em><a href="https://medium.com/@wladimirjimenezalonso"><em>Wladimir Alonso</em></a></p><p>Those who know Nassim Taleb, the author of ‘<a href="https://en.wikipedia.org/wiki/The_Black_Swan:_The_Impact_of_the_Highly_Improbable">The Black Swan</a>’, are likely acquainted with the notion that for people, institutions, and even countries to increase their chances of prospering in the long run they must be prepared for events that are improbable, but highly consequential (the so-called ‘black swans’). Take the case of earthquakes. Similar to other natural disasters, large magnitude earthquakes are highly unlikely in most places. Yet when they happen they can be accompanied by high death tolls, homelessness, the spread of infectious disease, the collapse of critical infrastructure and economic losses that may set a region back many years in terms of human development. Other events in this category include pandemics, civil unrest, war, floods and other natural disasters.</p><p>To insure against these events people, systems and nations must be properly prepared. But how should one prepare for something that we do not know whether and when will happen, or even how it will happen? One way would be by building resilience, that is, by developing the ability to survive in the face of adversity. Or better yet, by being ‘antifragile’, that is, by being able to learn and improve when confronted with adversity. For example, diversification and decentralization are antifragile strategies, as they reduce risk (by spreading options across different baskets) and allow improvement through experimentation. Conversely, preparing for the unexpected by trying to predict how exactly events will unfold is an extremely fragile strategy.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-Lb7ljTzWYTqU_JatXn8zw.jpeg" /></figure><p>One important factor that determines the fragility of a society is the degree to which the supply of critical resources, such as electricity, water and food, can be affected under adverse conditions. Food sources that are energetically demanding to produce, that rely on complex production chains involving many actors and rigorous logistical requirements, or that are highly perishable are intrinsically ‘fragile’, deteriorating and vanishing rapidly during disruptions. Animal-sourced foods are in this category: the production of animal products is nowadays characterized by complex chains requiring the constant supply of specialized feed and veterinary care, the maintenance of environmental conditions under narrow limits in those facilities where animals are kept, highly specific transportation conditions (including the transport of live animals among farms and from farms to slaughterhouses) and energetically demanding refrigeration requirements for the proper maintenance of final products. It is only natural that under disruptive scenarios, particularly those involving power outages, not only do these products become unavailable quickly, but also turn into a food safety concern in a matter of a day or two, increasing the risk of food-borne diseases. Conversely, other protein-rich sources of food such as beans, soy, lentils and chickpeas can be stored safely with minimum logistical requirements (including the absence of electricity), providing adequate nutrition for large groups of people for months if necessary. So initiatives and policies that teach society how to make proper use of ‘antifragile’ food sources can be a great asset in times of hardship.</p><p>Consider the case of Meatless Mondays, a program that promotes the replacement of animal-sourced foods by equally nutritious plant-based alternatives once a week. Present in many countries, the program was launched with a different purpose: the promotion of health (through the adoption of a diverse diet rich in vegetables) and sustainability (plant-based sources of protein require less natural resources than animal products). In Brazil, in particular, <a href="https://www.meatfreemondays.com/sao-paulos-mfm-programme-leads-world/">the initiative has been highly successful</a>, teaching the staff of over three thousand public schools how to cook nutritious and tasty meals with plant-based sources of protein, and creating the logistical conditions for their efficient provisioning.</p><p>We argue here that initiatives such as this provide yet another benefit: they increase national security by preparing society for a negative “Black Swan”, fostering the development of the know-how and logistics necessary to replace those food items that are more difficult to produce, store, and keep appropriate for consumption.</p><p>If so, there is in fact a strong case to be made for the expansion of Meatless Mondays or similar programs into other societal sectors, particularly those critical to ensuring the provision of essential services and civil order, such as public health facilities, emergency services, fire brigades, the armed and the military forces.</p><p>When properly implemented, what was originally designed as a resource-saving and healthy initiative could become a security booster for a whole country (don’t tell the enemy!).</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9f9df1762c30" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Intensification of animal production in the EU]]></title>
            <link>https://medium.com/@cynthiaschuck/intensification-of-animal-production-in-the-eu-8501e1b778f2?source=rss-bd593e71c791------2</link>
            <guid isPermaLink="false">https://medium.com/p/8501e1b778f2</guid>
            <category><![CDATA[poultry]]></category>
            <category><![CDATA[pigs]]></category>
            <category><![CDATA[factory-farming]]></category>
            <category><![CDATA[antibiotic-resistance]]></category>
            <category><![CDATA[animal-welfare]]></category>
            <dc:creator><![CDATA[Cynthia Schuck]]></dc:creator>
            <pubDate>Sun, 27 Jan 2019 13:32:55 GMT</pubDate>
            <atom:updated>2019-01-27T13:32:55.731Z</atom:updated>
            <content:encoded><![CDATA[<h4>How the European industry sees the effects of factory farming on animal health and welfare</h4><p>I have recently attended the last conference of the <a href="https://fp7-prohealth.eu/">PROHEALTH</a> Initiative, the largest ever project on farm animal health and welfare funded by the European Union — with total funding of €12 million and a consortium of 22 partners from the industry and academic sectors from six European countries. The project’s overall goal was to help combat production diseases commonly observed in pigs and poultry, namely those “<em>diseases which tend to persist in animal production systems and, typically, become more prevalent or severe in proportion to the potential productivity of the system</em>”, as defined by <a href="https://fp7-prohealth.eu/">PROHEALTH</a>. The focus on pigs and poultry (broilers, laying hens and turkeys) was only natural, as these are the most populous land species raised under intensive conditions.</p><p>The observed increase in the prevalence of production diseases is no surprise: productivity gains in the livestock industry have stemmed from the selection of fast-growing and highly productive animal breeds that produce more, eat less and can be slaughtered at a younger age, along with the manufacturing of highly specialized diets and additives designed to maximize the conversion of feed into meat, milk and eggs. These strategies brought down prices and made meat more affordable to many, particularly the poorer. However, they have come at a great cost to billions of animals raised under intensive conditions every year, stretching their physiological and anatomical limits far beyond those of naturally evolving biological systems. A high prevalence of physical injuries, disease and psychological disorders is not surprisingly the industry norm nowadays. Even if animals were allowed to roam free, life and reproduction in a natural environment would be nearly impossible for the average factory-farmed animal of today. <a href="https://en.wikipedia.org/wiki/Temple_Grandin">Temple Grandin</a> has referred to this problem as ‘<a href="https://www.sciencedirect.com/science/article/pii/S0309174014001314">biological system overload</a>’. In that sense, production diseases could be thought of as system overload alerts.</p><blockquote><strong>“Intensification of farming increases the risk and susceptibility of animals to production diseases” (<em>PROHEALTH)</em></strong></blockquote><p>Attending the event was, as I expected, very informative. Understanding the expectations from stakeholders across the production chain (producers, abattoirs, veterinarians, drug companies, processors, as well as scholars) regarding the future of factory farming, in a region (the EU) that has been regarded as the most concerned with animal welfare issues, seemed to be critical to understand the sector incentives to improve (at least some aspects of) animal health and welfare, which directions are being taken, and how they will affect farm animals in the short and long run. The main question I was seeking answers to was that addressing the sort of change one could expect to emerge naturally from the industry. Specifically, I was curious to see the extent to which the project addressed increasing societal concerns relating to animal welfare and a reversal towards more humane breeds and housing conditions.</p><h3><strong><em>Acknowledging the problem</em></strong></h3><p>Two things about the very existence of the <a href="https://fp7-prohealth.eu/">PROHEALTH </a>initiative stroke me as positive before I landed in the medieval city of Gent, in Belgium, where the last conference of PROHEALTH took place. First, the formal and explicit recognition by various stakeholders that intensification has bred a long list of health and welfare problems for animals. In the event, pneumonia, pleuritis, enteric diseases, ulcers, lameness, bone fractures and reproductive issues such as mastitis, metritis and other genitourinary infections were among the many common problems acknowledged and discussed as a direct result of intensification. Other figures presented included high piglet mortality rates, a high prevalence of body lesions resulting from aggression as well as different types of foot and leg disorders. Although the perspective taken greatly focused on the efficiency and financial losses these problems represent, I saw the formal acknowledgement of intensification as the root of the problem as a step forward towards dispelling claims on the contrary.</p><p><strong>“<em>Treatment and control [of production diseases] is the major reason for the use of antibiotics in the food chain</em>” (PROHEALTH)</strong></p><p>A second positive surprise was the formal acknowledgement that production diseases are the main responsible for the use of antibiotics in the food chain. Although antibiotics should be valued — and used — as a therapeutic tool to ensure proper treatment of sick animals, their prophylactic use in large scale to prevent disease was a key piece enabling the intensification of animal production worldwide, as it made the survival of large numbers of frail animals possible in the barren, crowded and strenuous conditions typical of factory farms. In the opening talks of the event, Dr. Sandra Edwards and Dr. Ilias Kyriazakis indeed highlighted that “<em>treatment and </em><strong><em>control </em></strong>[of production diseases]<em> is the major reason for the use of antibiotics in the food chain</em>”. This is despite the fact that <a href="http://www.saveourantibiotics.org/media/1777/asoa-report-real-farming-solutions-to-antibiotic-misues-what-farmers-and-supermarkets-must-do.pdf">the link between farming systems and antibiotic use has been often denied</a> by some sectors of the government and industry.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*qepzI8W2x-YRKeC47ahxqQ.jpeg" /><figcaption>In the intensive farms investigated by PROHEALTH, approximately 1 in every 5 piglets born alive will die prematurely from injury or disease (image: Stockphoto).</figcaption></figure><h3>The way forward, as seen by the industry</h3><p><a href="https://fp7-prohealth.eu/">PROHEALTH </a>focused on the understanding of the multi-factorial nature of animal pathologies linked to the intensification of production, their (environmental, genetic, developmental, immunological) risk factors, as well as the design of strategies to reduce their prevalence in socially acceptable ways.</p><p>Major strategies discussed included those tailored to reduce the likelihood of contamination and dissemination of infectious diseases (through measures such as vaccination, the implementation of higher levels of internal and external biosecurity and improvements in hygiene), the monitoring of environmental and immunological conditions (particularly those predictive of disease) to enable timely diagnosis and intervention, and the fine-tuning of nutritional management, probiotics and other supplements to improve animal health (e.g. gut and bone health). Specific improvements of welfare (<a href="https://fp7-prohealth.eu/knowledge-platform/scientific-publications/peer-reviewed-publications/sow-environment-during-gestation-part-i-influence-maternal-physiology-and-lacteal-secretions-relation-neonatal-survival/">such as enrichment at specific production phases</a>, selection of positive maternal traits and care with runt piglets) were also addressed.</p><p>Still, although the very definition of production diseases explicitly identifies the intensification of production as the driver of the problem, it was clear that the strategies developed to reduce the prevalence of these diseases were devised so as not to compromise productivity. Multi-factorial welfare reform or approaches tailored towards higher overall levels of animal welfare (e.g. use of slower-growing or less prolific breeds, higher space allowance, mitigation of chronic frustration resulting from deprivation of basic behavioral needs and measures to reduce the need for painful physical alterations such as tail docking) were something I did not see addressed in the event or in the materials available in their website. Nor were strategies to foster effective compliance with welfare legislation discussed. Instead, the focus seemed to be placed on combating those diseases associated with the higher financial losses to producers. For example, in the case of pigs, the project estimates that production diseases cost to producers approximately €30–40 per animal, with the main costs due to respiratory and enteric diseases, as well as neonatal mortality.</p><p>To what extent the production costs and welfare costs of diseases correlate? In other words, what are the costs of welfare issues of varying severity to producers? Other than the fact that more prevalent diseases affect the welfare of more animals (and by affecting more animals are more costly to producers), there is of course no necessary correlation between financial losses and the distress a disease causes to each animal. In fact, the very fact that animal health and welfare have deteriorated along with the intensification of production practices (as measured, for instance, through the increase in the frequency of production diseases, the need for physical alterations to reduce the harms of the aggressive interactions emerging as a by-product of chronic stress and the high frequency of behavioral anomalies that are not seen under natural settings) attest to the profitability of intensification. For example, the financial losses resulting from the death of a fraction of individuals are often compensated by larger gains at the farm level accrued with the push for higher productivity. In the case of female breeders, high replacement rates (due to reproductive failures, death and a myriad of other problems affecting these mothers) are also often compensated by the extremely high litter numbers they produce in their short lives. In fact, societal pressure is needed exactly because the interests of animals and producers are out of line.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*dNCuhpxTUWupsmvwyFCaXQ.jpeg" /><figcaption>Standard housing system for chickens (image: Stockphoto)</figcaption></figure><p>In terms of the social acceptability of practices, a study presented by Beth Clark, from Newcastle University, <a href="https://www.theguardian.com/food/2018/nov/16/theres-no-such-thing-as-humane-meat-or-eggs-stop-kidding-yourself">confirmed once more</a> that consumers are often unfamiliar with current production methods, with a large knowledge gap between what consumers believe about the origins of their food and what they in fact eat (as estimated from sales data). Although most consumers see intensive production methods negatively, they believe the animal products they consume do not come from factory farms [a statistical impossibility, as &gt;95% products have their origins in factory farms]. Properly informing consumers in that specific regard would be thus essential to create the market incentives needed for broader system reform.</p><blockquote>“<strong>No system or procedure is sustainable if a substantial proportion of people find aspects of it now, or of its consequences in the future, morally unacceptable</strong>”<strong> (Donald Broom)</strong></blockquote><p>Overall, my impression is that this was a well organized project, but that from an animal welfare perspective failed to address critical issues associated with the intensification of production systems. This is particularly the case for those welfare offenses with no obvious effects on product yield and quality, such as those associated with fear, anxiety and frustration, or those compensated by productivity gains at larger scales. Although the strategies proposed by PROHEALTH do seem to improve some dimensions of animal health, since they are focused on workarounds of only some of the detrimental effects of intensification — and those workarounds that lead to improvements in efficiency — their indirect and flow-through effects in terms of positive change for animals may be in fact the opposite. These observation stress once more the natural conflict that exists between ensuring that animals can indeed experience a ‘good life’ and the uncompromising focus on productivity and production costs.</p><p>Do the strategies devised by PROHEALTH make intensive systems more sustainable, as intended by the project? I say they don’t though. Sustainability requires social acceptability. As put forward by Donald Broom, a well-known scholar from Cambridge University and Vice-Chairman of European Food Safety Authority Panel on Animal Health and Welfare, “<em>no system or procedure is sustainable if a substantial proportion of people find aspects of it now, or of its consequences in the future, morally unacceptable. One major reason why animal production systems may be regarded by the public as unacceptable, and hence become unsustainable without some modification, is the welfare of the animals used in the production system</em>”. As citizens, investors and other decision-makers become increasingly aware of the many harms and risks associated with intensive farming systems, a shift away from these systems will be sooner or later inevitable.</p><p>[my portrayal of <a href="https://fp7-prohealth.eu/">PROHEALTH </a>is limited to my short, two-days, experience in the event, so it’s limited in scope and depth. Comments, criticisms and further input are most welcomed. I would like to thank the organizers for the invitation and for welcoming me to the event]</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8501e1b778f2" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>